PetMed Express (NASDAQ: PETS) reported Q2 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $71.4 million versus the consensus estimate of $72 million.

For earnings history and earnings-related data on PetMed Express (PETS) click here.